Mergers & Acquisitions - Mergers & Acquisitions, Generics

Filter

Popular Filters

101 to 125 of 180 results

Watson acquires Uteron Pharma; confirms Opana patent challenge

24-01-2013

US generic and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) says that it has completed the…

Endo PharmaceuticalsGenericsGrunenthalMergers & AcquisitionsNeurologicalNorth AmericaOpanaPatentsPharmaceuticalUteron PharmaWatson PharmaceuticalsWomen's Health

Adcock Ingram closes Indian acquisition; Simcere sheds Shanghai Celgen stake

22-01-2013

South Africa's largest health care company Adcock Ingram (AIP: SJ) has announced the completion of the…

Adcock IngramAsia-PacificCosme FarmaGenericsMergers & AcquisitionsShanghai Celgen Bio-PharmaceuticalsSimcere Pharmaceutical

GlobalData views potential of Pfizer's rumored acquisition of Strides' Agila unit

20-01-2013

As drug makers continue to jostle for market share and deal with declining revenues from their off-patent…

Agila SpecialitesGenericsMergers & AcquisitionsPfizerPharmaceuticalStrides Arcolab

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

2012 again a bumper year for Pharma M&A, but values well down

09-01-2013

The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012

07-01-2013

Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

Japan Pharma: Expectations for 2013, by P Reed Maurer

03-01-2013

The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

JHP Pharmaceuticals acquired by Warburg Pincus for $195 million

02-01-2013

US specialty drugmaker JHP Pharmaceuticals, which acquires, develops, manufactures and sells sterile…

GenericsJHP PharmaceuticalsMergers & AcquisitionsPharmaceuticalWarburg Pincus

Perrigo buys full control of Cobrek Pharma for about $45 million

31-12-2012

US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

DCC Healthcare acquires generic drugmaker Kent Pharma

24-12-2012

Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that…

Antibiotics and Infectious diseasesDCC HealthcareGenericsKent PharmaceuticalMergers & Acquisitions

No "Japan pharma for sale signs," by P Reed Maurer

18-12-2012

Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

News briefs: US Crestor patent upheld; Pfizer animal health plans; Teva South Korea JV

17-12-2012

Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal…

Asia-PacificAstraZenecaCrestorGenericsHandok PharmaceuticalsLegalMergers & AcquisitionsNorth AmericaPatentsPfizerPharmaceuticalTeva Pharmaceutical IndustriesZoetis

Kemira sells ChemSolutions' food and pharma businesses to Niacet

16-12-2012

Finland-based water chemistry specialist Kemira Oyj (OMX: KRA1V) has signed an agreement to sell its…

GenericsKemiraMergers & AcquisitionsNiacet

India's Elder Pharma to enter EU markets; comment on GSK Indian OTC moves

26-11-2012

Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following…

Asia-PacificdiosminElder PharmaceuticalsEuropeGenericsGlaxoSmithKlineMarkets & MarketingMergers & AcquisitionsPharmaceuticalRegulation

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Validus Pharma gets rights to six Novartis drugs in USA

19-11-2012

USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired…

GenericsMergers & AcquisitionsNovartisValidus Pharma

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma

15-11-2012

US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

AFK Sistema cleared to take over Russian drugmaker Veropharm

14-11-2012

Shares in Russian companies 36.6 and Veropharm surged in Monday afternoon trading on the Moscow Stock…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalRegulationVeropharm

AFK Sistema may acquire Russian drugmaker Veropharm

06-11-2012

AFK Sistema, the financial conglomerate owned by the Russian billionaire Vladimir Yevtushenko, is considering…

AFK SistemaGenericsMergers & AcquisitionsPharmaceuticalVeropharm

Forest Labs links with moksha8 for Viibryd in Latin America; Watson sells minority stake

24-10-2012

US drugmaker Forest Laboratories (NYSE: FRX) has entered into a broad strategic alliance with Brazil-based…

Forest LaboratoriesGenericsLicensingMergers & AcquisitionsMoksha8NeurologicalPharmaceuticalSouth AmericaViibrydWatson Pharmaceuticals

101 to 125 of 180 results

Back to top